146 related articles for article (PubMed ID: 8893409)
1. Development of listeriosis during vancomycin therapy in a neutropenic patient.
Arsene O; Linassier C; Quentin R; Legras A; Colombat P
Scand J Infect Dis; 1996; 28(4):415-6. PubMed ID: 8893409
[TBL] [Abstract][Full Text] [Related]
2. Fever and neutropenia during intensive chemotherapy.
Klastersky J
Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
[No Abstract] [Full Text] [Related]
3. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
4. Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment.
Chang J; Powles R; Mehta J; Paton N; Treleaven J; Jameson B
Clin Infect Dis; 1995 Nov; 21(5):1289-90. PubMed ID: 8589157
[TBL] [Abstract][Full Text] [Related]
5. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
[TBL] [Abstract][Full Text] [Related]
6. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
7. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
[TBL] [Abstract][Full Text] [Related]
8. [Fever in patients with cancer].
Watanabe K
Rinsho Byori; 2009 May; Suppl 143():112-5. PubMed ID: 20845880
[No Abstract] [Full Text] [Related]
9. Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.
Jones EM; MacGowan AP
Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):165-75. PubMed ID: 7614955
[TBL] [Abstract][Full Text] [Related]
10. Listeria monocytogenes endocarditis in a patient on chronic hemodialysis, successfully treated with vancomycin-gentamicin.
Gallagher PG; Amedia CA; Watanakunakorn C
Infection; 1986; 14(3):125-8. PubMed ID: 3733226
[TBL] [Abstract][Full Text] [Related]
11. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
[TBL] [Abstract][Full Text] [Related]
12. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
13. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
[TBL] [Abstract][Full Text] [Related]
14. Fatal Bacillus cereus endocarditis masquerading as an anthrax-like infection in a patient with acute lymphoblastic leukemia: case report.
Cone LA; Dreisbach L; Potts BE; Comess BE; Burleigh WA
J Heart Valve Dis; 2005 Jan; 14(1):37-9. PubMed ID: 15700434
[TBL] [Abstract][Full Text] [Related]
15. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy.
Skogberg K; Syrjänen J; Jahkola M; Renkonen OV; Paavonen J; Ahonen J; Kontiainen S; Ruutu P; Valtonen V
Clin Infect Dis; 1992 Apr; 14(4):815-21. PubMed ID: 1341415
[TBL] [Abstract][Full Text] [Related]
17. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
18. Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients.
Smith SR; Cheesbrough J; Harding I; Davies JM
Br J Haematol; 1990 Dec; 76 Suppl 2():54-6. PubMed ID: 2149054
[TBL] [Abstract][Full Text] [Related]
19. Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Nucci M; Landau M; Silveira F; Spector N; Pulcheri W
Infect Control Hosp Epidemiol; 2001 Oct; 22(10):651-3. PubMed ID: 11776354
[TBL] [Abstract][Full Text] [Related]
20. What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
Tattevin P; Camus C
Clin Infect Dis; 2006 Jun; 42(12):1813-4; author reply 1814-5. PubMed ID: 16705599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
